Detalhe da pesquisa
1.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497158
2.
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Eur J Nucl Med Mol Imaging
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795120
3.
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
Int J Mol Sci
; 25(2)2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255842
4.
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Blood
; 138(9): 773-784, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876209
5.
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia.
Int J Mol Sci
; 24(19)2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833915
6.
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine.
Curr Opin Oncol
; 34(6): 738-747, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017547
7.
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 60(7): 482-488, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611795
8.
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 20(12)2019 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226848
9.
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Int J Cancer
; 143(4): 958-970, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508386
10.
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(7): e27062, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603593
11.
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.
Hemasphere
; 8(3): e51, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463444
12.
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.
Vascul Pharmacol
; 146: 107110, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103993
13.
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy.
Leukemia
; 36(2): 348-360, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341479
14.
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
Tumori
; 108(1): 86-92, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730957
15.
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Cell Death Dis
; 13(6): 551, 2022 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710782
16.
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
Cancers (Basel)
; 14(12)2022 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740677
17.
Identification of AML1-ETO modulators by chemical genomics.
Blood
; 113(24): 6193-205, 2009 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19377049
18.
Targeting oncogenic Notch signaling with SERCA inhibitors.
J Hematol Oncol
; 14(1): 8, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407740
19.
Lenvatinib Targets PDGFR-ß Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
J Clin Endocrinol Metab
; 106(12): 3569-3590, 2021 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302727
20.
Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis.
Cancers (Basel)
; 13(11)2021 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067466